UC Davis researchers find molecule that targets brain tumors

December 30, 2008

New discovery could allow for direct delivery of treatments

(SACRAMENTO, Calif.) - UC Davis Cancer Center researchers report today the discovery of a molecule that targets glioblastoma, a highly deadly form of cancer. The finding, which is published in the January 2009 issue of the European Journal of Nuclear Medicine and Molecular Imaging, provides hope for effectively treating an incurable cancer.

Glioblastoma is the most common and aggressive type of primary brain tumor in adults. It is marked by tumors with irregular shapes and poorly defined borders that rapidly invade neighboring tissues, making them difficult to remove surgically.

"These brain tumors are currently treated with surgery to remove as much of the tumor as possible followed by radiation to kill cancer cells left behind and systemic chemotherapy to prevent spread to nearby tissues," said Kit Lam, senior author of the study and UC Davis chief of hematology and oncology. "It is unfortunate that this approach does not extend survival significantly. Most patients survive less than one year."

To find new options for treating the disease, Lam and his colleagues began searching for a molecule that could be injected into a patient's bloodstream and deliver high concentrations of medication or radionuclides directly to brain tumor cells while sparing normal tissues. Through their study, they identified a molecule - called LXY1 - that binds with high specificity to a particular cell-surface protein called alpha-3 integrin, which is overexpressed on cancer cells.

They also tested the molecule's ability to target brain cancer by implanting human glioblastoma cells both beneath the skin and in the brains of mice. The researchers injected the mice with a radiolabeled version of LXY1 and, using near-infrared fluorescence imaging, showed that the molecule did preferentially bind to human glioblastoma cells in both locations.

"This outcome gives us great hope that we will be able to deliver targeted therapies to treat glioblastoma," said Lam.

Lam is planning to continue this work by repeating the experiments with powerful cancer treatments linked to the LXY1 molecule. They will begin with iodine-131, a form of radionuclide currently used to treat some cancers, as well as a nanoparticle, or "smart bomb," that would carry cancer-fighting drugs to diseased cells.

University of California - Davis - Health System

---

---

	Medifocus Guidebook on: Glioblastoma by Medifocus.com Inc. (Author), Elliot Jacob PhD. (Editor) The MediFocus Guidebook on Glioblastoma is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Glioblastoma, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Glioblastoma, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and support organizations...
	Surviving Terminal Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About by Ben A. Williams (Author) Describes how to use the Internet and other sources to learn about experimental drug trials, effective forms of alternative medicine, and other breakthroughs with the potential for dramatically improving the odds of successful treatment.
	Glioblastoma Multiforme by James Markert (Author), Vincent T. DeVita Jr. (Author), Steven A. Rosenberg (Author), Samuel Hellman (Author) This Book Provides Basic Researchers And Clinicians With A Contemporary Review Of The Epidemiology, Diagnosis, And Treatment Of Glioblastoma Multiforme, The Most Common And Most Deadly Type Of Brain Tumor. Expert Malignant Glioma Researchers And Clinicians Provide State-Of-The-Art Chapters On Important Topics Such As Molecular Genetic Classification Of Glioblastoma, Surgical Management, Stem Cell Therapy, Chemotherapy, Angiogenesis, And More.
	Damn The Statistics, I Have a Life to Live!: Coping with a Brain Tumor My Personal Story by Harry Wolf (Author) June 3, 2002 was the day that changed my life forever.  A 43-year-old father of three, whom in oneday went from being a successful senior manager to a man with a braintumor.  I have a glioblastoma multiformegrade IV brain tumor, the most deadly and aggressive type of brain tumor.  This book covers how I have dealt with lifeafter being informed that I have a tumor that only 1-2% survive for 2years.  I share the experiences, thoughts,and events from my first year as a survivor. When I was first diagnosed, I searched for a book that covered thedetails of what could be expected on both a medical and personal level.  I could not find, so I wrote one.  I maintained a detailed journal.  I cover the first surgery, an awakecraniotomy, and the subsequent head infection that led to a second...
	What You Need to Know About Glioblastoma Cancer - It's Your Life, Live It! by Cancer Group Institute As an Oncology Nurse. I had only one protocol in mind while writing this 195 page book. That was to show you the most successful cancer treatments available today for Glioblastoma Cancer. To that end, you won't find a better warrior in the war on cancer than reading this book. We are honored to inform you that many leading hospitals use our books in their medical library to be used by physicians. They are Harvard University, Columbia, NYU, UCLA, Johns Hopkins, MD Anderson Cancer Center Orlando, Tift Regional Cancer Center, Instituto Oncologia Moderna, Puerto Rico plus many others. It is critical to get prompt diagnosis and proper treatment for glioblastoma cancer, this can literally make the difference between life and death. Understanding your options will give you...
	Glioblastoma:: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies by Swapan K. Ray (Editor) Glioblastoma is the most malignant brain tumor that still remains incurable. It is such a deadly disease that patients do not survive more than a few months after diagnosis. Our understanding of the histopathology and molecular mechanisms of formation of glioblastoma is rapidly advancing so as to provide us clues for devising rational therapeutic strategies for treatment of this malignancy. It is important that we continue to improve our knowledge about the pathogenesis of this devastating disease and explore new areas to find successful therapeutic strategies. Various approaches such as sophisticated imaging techniques, improved surgical procedures, ground-breaking strategies for radiotherapy, chemotherapy, immunotherapy, chemoimmunotherapy, and photodynamic therapy are being used for...
	Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1) by M. A. Hayat (Editor) The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.
	Living with a Brain Tumor: Dr. Peter Black's Guide to Taking Control of Your Treatment by Peter Black (Author) Each year, 100,000 people in the United States are diagnosed with a brain tumor. With his new book, Dr. Peter Black fills a gap in the lay readership, providing an accessible medical resource for adult patients and their families. Dr. Black, who has operated on more than 3,000 patients with brain tumors, is uniquely qualified to discuss both clinical treatment of and research into brain tumors. This invaluable resource tells patients everything they need to know to understand and address their diagnosis, in a four-part structure: • “What is a Brain Tumor?" provides straightforward information about how brain tumors are diagnosed, the different types of tumors and how they develop, and where to go for treatment. • “Coping with Shock” addresses the emotional...
	Tumors of the Central Nervous System, Volume 2: Gliomas: Glioblastoma (Part 2) by M.A. Hayat (Editor) Advantages and limitations of biomarkers in gliomagenesis are described. Molecular subtypes of gliomas are detailed. The role played by TP53 gene mutation in the deadliest brain tumor, glioblastoma multiforme, is pointed out. The role of mutations of IDH1 and IDH2, and isocitrate dehydrogenases in malignant gliomas are presented. Metabolic differences in different regions of the glioma tumor are clarified. Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Both low-grade and high-grade gliomas are discussed. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed. Impact of resection extent on outcomes in patients...
	Glioblastoma: Risk Factors, Diagnosis and Treatment Options (Cancer Etiology, Diagnosis and Treatment) by Marcelo F. Bezerra (Editor), Claudio R. Alves (Editor)